<DOC>
	<DOCNO>NCT00372970</DOCNO>
	<brief_summary>It hypothesize patient gastroparesis increase pyloric tone may contribute feature . Botox relax pylorus food empty stomach rapidly . Lesser quality study show treatment work 40 % patient , relieve symptom 3 month . This study compare treatment placebo ( saline ) injection . After 1 month period patient may elect receive open label botox receive relief first injection . Patients symptoms gastric empty follow 1 year .</brief_summary>
	<brief_title>Placebo Controlled Trial Botulinum Toxin Gastroparesis</brief_title>
	<detailed_description>Patients gastroparesis , delay gastric empty , present early satiety , postprandial bloating , nausea , vomit , abdominal pain discomfort.1 Gastric empty highly regulate process reflect integration propulsive force generate proximal fundic tone distal antral contraction resistance pyloric sphincter . Antral hypomotility well increase gastric outlet resistance due pyloric dysfunction pylorospasm appear important physiologic disturbance gastroparesis.2-4 Current treatment gastroparesis employ prokinetic agent increase antral contractility accelerate gastric emptying.5 Unfortunately , prokinetic agent limited efficacy trial agent suffer significant methodological flaws.6 Troublesome side effect cardiac arrhythmias case cisapride ( Propulsid , Janssen Pharmaceutica ) extrapyramidal symptom sedation case metoclopramide ( Reglan , A.H. Robins ) limit usefulness agents.7 Domperidone may effective treating symptom gastroparesis , however unavailable U.S.8 Botulinum toxin ( Botox , Allergan ) inhibitor cholinergic neuromuscular transmission use treat spastic disorder striate smooth muscle local injection affect muscles.9 Previous publish work institution demonstrate injection botulinum toxin pylorus improve gastric empty reduces symptom idiopathic gastroparesis.10 In open label study , patient 38 % reduction gastroparesis symptom interview 4 week injection . Seventy percent patient improve gastric emptying . No immediate short term ( within 6 month ) untoward event occur study . The beneficial effect botulinum toxin injection suggest decrease pyloric resistance ; however , manometric analysis region perform . Our result similar see study demonstrate accelerated gastric empty response pyloric botulinum toxin injection.11-13 These study include group patient idiopathic diabetic gastroparesis . Unfortunately , study , patient group small study design open label might bias result favor positive response . In addition , follow-up 6 month . Despite limited data , many gastroenterologist use botulinum toxin injection treatment gastroparesis outside context clinical research study . We concerned practice may increase nationwide without definitive proof efficacy . A randomized , placebo-controlled trial necessary establish usefulness pyloric botulinum toxin injection gastroparesis . Botulinum toxin therapy expensive may efficacious . In addition , efficacious , mechanism botulinum toxin improve gastric empty need study . This research protocol answer several question concern potentially useful therapy gastroparesis .</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Documented gastroparesis radiologic study No ulcer disease Only surgery history must either appendectomy cholecystectomy No prior treatment Botox Prior botox injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>gastroparesis</keyword>
	<keyword>vomit</keyword>
	<keyword>nausea</keyword>
	<keyword>bloating</keyword>
	<keyword>dyspepsia</keyword>
</DOC>